Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 8:12 PM UTC
| NCT Number | NCT06588413 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 172 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Augusta University |
| Last Updated on CT.gov | November 22, 2024 (Nov 22, 2024) |
As of July 21, 2026: Clinical trial NCT06588413 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Augusta University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06588413 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06588413 was last updated Nov 22, 2024 (November 22, 2024). HelloStudys verifies this status automatically.